Lys79
Javascript is not enabled on this browser. This site will not work properly without Javascript.
PhosphoSitePlus Homepage PhosphoSitePlus® v6.7.1.1
Powered by Cell Signaling Technology
Home > Di-methylation Site Page: > Lys79  -  H3F3A (human)

Site Information
REIAQDFktDLrFQs   SwissProt Entrez-Gene
Blast this site against: NCBI  SwissProt  PDB 
Site Group ID: 18545333

In vivo Characterization
Methods used to characterize site in vivo:
mass spectrometry ( 1 , 2 , 3 , 4 , 5 )
Relevant cell line - cell type - tissue:

Downstream Regulation
Effects of modification on H3F3A:
molecular association, regulation ( 3 )
Induce interaction with:
L3MBTL iso4 (human) ( 3 )

References 

1

Guo A, et al. (2014) Immunoaffinity enrichment and mass spectrometry analysis of protein methylation. Mol Cell Proteomics 13, 372-87
24129315   Curated Info

2

Bremang M, et al. (2013) Mass spectrometry-based identification and characterisation of lysine and arginine methylation in the human proteome. Mol Biosyst 9, 2231-47
23748837   Curated Info

3

Moore KE, et al. (2013) A general molecular affinity strategy for global detection and proteomic analysis of lysine methylation. Mol Cell 50, 444-56
23583077   Curated Info

4

Mulhern D (2011) CST Curation Set: 13061; Year: 2011; Biosample/Treatment: cell line, HCT116/untreated; Disease: colorectal carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: m2K
Curated Info

5

Possemato A (2008) CST Curation Set: 5337; Year: 2008; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: m2K
Curated Info